TERUMO MEDICAL CORPORATION
Manufacturer adverse-event records for TERUMO MEDICAL CORPORATION come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 1993–2026 · mid-book · typical Death-code · balanced
Injury-mix signature
TERUMO MEDICAL CORPORATION keeps a balanced Injury share
Injury-coded event_type share is 46.3% (balanced tercile) beside 0.33% Death-coded (typical). Volume band: mid.
What the Injury-mix reading shows for TERUMO MEDICAL CORPORATION
The standout signal for TERUMO MEDICAL CORPORATION is Injury-mix: 46.3% Injury-coded (balanced) beside 0.33% Death-coded, on a mid-book footprint.
Mid-pack volume still shows a clear device fingerprint; the table below is the actionable layer for TERUMO MEDICAL CORPORATION. Event_type Death/Injury codes differ from patient-outcome rows - see methodology.
Reports span 20 device types, led in this extract by Malfunction at 6,208 (53.3% of event_type total). Peak single-year volume reaches 1,566 reports across 34 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (20)
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.